TG Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
03.11.25
/
50%
€29.03
Target price
03.11.26
€42.51
Performance (%)
25.41%
Price
08.05.26
€36.40
Summary
This prediction is currently active. The prediction currently has a performance of 25.41%. This prediction currently runs until 03.11.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| TG Therapeutics Inc. | 26.389% | 26.389% |
| iShares Core DAX® | 0,22 % | 1,49 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % |
| iShares S&P 500 | 2,17 % | 8,06 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread TG Therapeutics Inc. diskutieren
TG Therapeutics (NASDAQ:TGTX) had its price target raised by analysts at JPMorgan Chase & Co. from $46.00 to $49.00. They now have an "overweight" rating on the stock.
Ratings data for TGTX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for TG Therapeutics Inc.
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.75
02.02.26
02.02.26
€38.74
02.02.27
02.02.27
47.07%
08.05.26
08.05.26
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€34.10
25.11.24
25.11.24
€40.92
25.11.25
25.11.25
-17.20%
26.11.25
26.11.25
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.95
19.04.24
19.04.24
€23.48
19.04.25
19.04.25
142.08%
20.04.25
20.04.25
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.50
01.11.23
01.11.23
€21.76
01.11.24
01.11.24
163.21%
02.11.24
02.11.24
TG Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.89
07.08.23
07.08.23
€19.99
07.08.24
07.08.24
106.21%
08.08.24
08.08.24